Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 6302748, 9 pages
https://doi.org/10.1155/2018/6302748
Research Article

Optimized Extract from Corylopsis coreana Uyeki (Hamamelidaceae) Flos Inhibits Osteoclast Differentiation

1Department of Pharmacy, Sunchon National University, Jeonnam, Suncheon 57922, Republic of Korea
2Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan, Jeonnam 58554, Republic of Korea

Correspondence should be addressed to Seung-Sik Cho; rk.ca.opkom@ohcss and Young-Jin Son; rk.ca.nohcnus@ynos

Received 15 September 2017; Revised 23 December 2017; Accepted 30 January 2018; Published 6 March 2018

Academic Editor: Michał Tomczyk

Copyright © 2018 Yongjin Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Boyle, W. S. Simonet, and D. L. Lacey, “Osteoclast differentiation and activation,” Nature, vol. 423, no. 6937, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Baud'huin, L. Duplomb, C. Ruiz Velasco, Y. Fortun, D. Heymann, and M. Padrines, “Key roles of the OPG-RANK-RANKL system in bone oncology,” Expert Review of Anticancer Therapy, vol. 7, no. 2, pp. 221–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Takayanagi, “The role of NFAT in osteoclast formation,” Annals of the New York Academy of Sciences, vol. 1116, pp. 227–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Takayanagi, S. Kim, T. Koga et al., “Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts,” Developmental Cell, vol. 3, no. 6, pp. 889–901, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Kim, S. Y. Ha, M. H. Oh, H. H. Kim, S. R. Kim, and M. W. Lee, “Anti-oxidative and anti-proliferative activity on human prostate cancer cells lines of the phenolic compounds from Corylopsis coreana Uyeki,” Molecules, vol. 18, no. 5, pp. 4876–4886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Wang, G. J. Provan, and K. Helliwell, “Determination of hamamelitannin, catechins and gallic acid in witch hazel bark, twig and leaf by HPLC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 33, no. 4, pp. 539–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Seo, J. Kim, J. Shim et al., “HPLC analysis, optimization of extraction conditions and biological evaluation of Corylopsis coreana uyeki flos,” Molecules, vol. 21, no. 1, p. 94, 2016. View at Publisher · View at Google Scholar
  8. I.-S. Yoon, D.-H. Park, S.-H. Ki, and S.-S. Cho, “Effects of extracts from Corylopsis coreana Uyeki (Hamamelidaceae) flos on xanthine oxidase activity and hyperuricemia,” Journal of Pharmacy and Pharmacology, vol. 68, no. 12, pp. 1597–1603, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Yin and L. Li, “The stem cell niches in bone,” The Journal of Clinical Investigation, vol. 116, no. 5, pp. 1195–1201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mansour, G. Abou-Ezzi, E. Sitnicka, S. E. W. Jacobsen, A. Wakkach, and C. Blin-Wakkach, “Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow,” The Journal of Experimental Medicine, vol. 209, no. 3, pp. 537–549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Li, L. Zeng, J. Xie et al., “Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops,” Scientific Reports, vol. 5, Article ID 17605, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Zheng, X. Yu, P. Collin-Osdoby, and P. Osdoby, “RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts: An autocrine negative feedback mechanism triggered by RANKL-induced interferon-β via NF-κB that restrains osteoclastogenesis and bone resorption,” The Journal of Biological Chemistry, vol. 281, no. 23, pp. 15809–15820, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Matsumoto, T. Sudo, M. Maruyama, H. Osada, and M. Tsujimoto, “Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor,” FEBS Letters, vol. 486, no. 1, pp. 23–28, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Ikeda, R. Nishimura, T. Matsubara et al., “Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-requlated osteoclast differentiation,” The Journal of Clinical Investigation, vol. 114, no. 4, pp. 475–484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-Y. Choe and S.-K. Kim, “Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages,” International Journal of Molecular Medicine, vol. 39, no. 3, pp. 539–548, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. J. An, H. Yang, Q. Zhang et al., “Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation,” Life Sciences, vol. 147, pp. 46–58, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Nazir, S. Koul, M. A. Qurishi et al., “Immunomodulatory effect of bergenin and norbergenin against adjuvant-induced arthritis—a flow cytometric study,” Journal of Ethnopharmacology, vol. 112, no. 2, pp. 401–405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Oliveira, C. A. Figueiredo, C. Brito et al., “Allium cepa L. and quercetin inhibit RANKL/ porphyromonas gingivalis LPS-induced osteoclastogenesis by downregulating NF-κB signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 704781, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Derakhshanian, M. Djalali, A. Djazayery et al., “Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 5, pp. 380–385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Satué, M. del Mar Arriero, M. Monjo, and J. M. Ramis, “Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells,” Biochemical Pharmacology, vol. 86, no. 10, pp. 1476–1486, 2013. View at Publisher · View at Google Scholar
  21. T. Koga, M. Inui, K. Inoue et al., “Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis,” Nature, vol. 428, no. 6984, pp. 758–763, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. C. Hofbauer and M. Schoppet, “Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases,” The Journal of the American Medical Association, vol. 292, no. 4, pp. 490–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Weiss, A. C. Renkl, C. S. Maier et al., “Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes,” The Journal of Experimental Medicine, vol. 194, no. 9, pp. 1219–1229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Bromme and K. Okamoto, “Human Cathepsin 02, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution,” Biological Chemistry Hoppe-Seyler, vol. 376, no. 6, pp. 379–384, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Kafienah, D. Brömme, D. J. Buttle, L. J. Croucher, and A. P. Hollander, “Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix,” Biochemical Journal, vol. 331, part 3, pp. 727–732, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Boonen, E. Rosenberg, F. Claessens, D. Vanderschueren, and S. Papapoulos, “Inhibition of cathepsin K for treatment of osteoporosis,” Current Osteoporosis Reports, vol. 10, no. 1, pp. 73–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Sapkota, L. Li, H. Choi, W. H. Gerwick, and Y. Soh, “Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways,” European Journal of Pharmacology, vol. 769, pp. 100–109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. E. Otero, S. Dai, M. A. Alhawagri, I. Darwech, and Y. Abu-Amer, “IKKβ activation is sufficient for RANK-independent osteoclast differentiation and osteolysis,” Journal of Bone and Mineral Research, vol. 25, no. 6, pp. 1282–1294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. T.-J. Sheu, E. M. Schwarz, D. A. Martinez et al., “A phage display technique identifies a novel regulator of cell differentiation,” The Journal of Biological Chemistry, vol. 278, no. 1, pp. 438–443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. H. Kim, K. Kim, H. M. Jin et al., “Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1,” The Journal of Biological Chemistry, vol. 285, no. 8, pp. 5224–5231, 2010. View at Publisher · View at Google Scholar · View at Scopus